This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Polycystic ovary syndrome (PCOS) is a common disorder among women, diagnosed in at least 5% to 10% of women between adolescence and menopause. Symptoms include menstrual dysfunction and hyperandrogenism. Insulin resistance and hyperinsulinemia may play a role in PCOS by promoting excess androgen production, and insulin sensitizing agents like metformin have resulted in improved clinical status in some adult women. Investigators from the University of Newfoundland in St. Johns and McGill University in Montreal performed a randomized, placebo-controlled, double-blind trial using metformin for PCOS in adolescents. A total of 22 adolescents with hyperinsulinemia and PCOS were enrolled from the ambulatory endocrinology adolescent clinic at Montreal Children’s Hospital between 1999 and …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.